Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-a in high-risk melanoma patients

AR Gool; H Ojik; Wim Kruit; PGH (Paul) Mulder; Durk Fekkes; M Bannink; S Scharpé; Gerrit Stoter; Lex Eggermont; M Maes; R Verkerk

doi:10.1089/1079990041535629

Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-a in high-risk melanoma patients

AR Gool, H Ojik, Wim Kruit, PGH (Paul) Mulder, Durk Fekkes, M Bannink, S Scharpé, Gerrit Stoter, Lex Eggermont, M Maes, R Verkerk

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	411-415
Number of pages	5
Journal	Journal of Interferon and Cytokine Research
Volume	24
DOIs	https://doi.org/10.1089/1079990041535629
Publication status	Published - 2004

Research programs

EMC MM-03-47-11
EMC MM-03-86-12
EMC NIHES-01-64-03
EMC ONWAR-01-94-01
EMC OR-01-58-01

Access to Document

10.1089/1079990041535629

http://hdl.handle.net/1765/58382

Cite this

Gool, AR., Ojik, H., Kruit, W., Mulder, PGH., Fekkes, D., Bannink, M., Scharpé, S., Stoter, G., Eggermont, L., Maes, M., & Verkerk, R. (2004). Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-a in high-risk melanoma patients. Journal of Interferon and Cytokine Research, 24, 411-415. https://doi.org/10.1089/1079990041535629

@article{194e8a878a2848e9b17a1a365b07df1a,

title = "Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-a in high-risk melanoma patients",

author = "AR Gool and H Ojik and Wim Kruit and Mulder, {PGH (Paul)} and Durk Fekkes and M Bannink and S Scharp{\'e} and Gerrit Stoter and Lex Eggermont and M Maes and R Verkerk",

year = "2004",

doi = "10.1089/1079990041535629",

language = "Undefined/Unknown",

volume = "24",

pages = "411--415",

journal = "Journal of Interferon and Cytokine Research",

issn = "1079-9907",

publisher = "Mary Ann Liebert Inc.",

}

Gool, AR, Ojik, H, Kruit, W, Mulder, PGH, Fekkes, D, Bannink, M, Scharpé, S, Stoter, G, Eggermont, L, Maes, M & Verkerk, R 2004, 'Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-a in high-risk melanoma patients', Journal of Interferon and Cytokine Research, vol. 24, pp. 411-415. https://doi.org/10.1089/1079990041535629

TY - JOUR

T1 - Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-a in high-risk melanoma patients

AU - Gool, AR

AU - Ojik, H

AU - Kruit, Wim

AU - Mulder, PGH (Paul)

AU - Fekkes, Durk

AU - Bannink, M

AU - Scharpé, S

AU - Stoter, Gerrit

AU - Eggermont, Lex

AU - Maes, M

AU - Verkerk, R

PY - 2004

Y1 - 2004

U2 - 10.1089/1079990041535629

DO - 10.1089/1079990041535629

M3 - Article

C2 - 15296652

SN - 1079-9907

VL - 24

SP - 411

EP - 415

JO - Journal of Interferon and Cytokine Research

JF - Journal of Interferon and Cytokine Research

ER -